Skip to main content

Table 2 Antimicrobial susceptibility profiles of enterococcal isolates investigated

From: Species, antibiotic susceptibility profiles and van gene frequencies among enterococci isolated from patients at Mulago National Referral Hospital in Kampala, Uganda

Drug E. faecalis, n = 72 E. faecium, n = 05 Others, n = 38
R (%) I (%) S (%) R (%) I (%) S (%) R (%) I (%) S (%)
Erythromycin 54 (72) 07 (9.7) 11 (15.3) 04 (80) 0 01 (20) 07 (18.4) 04 (10.5) 11 (28.9)
Tetracycline 50 (69.4) 0 22 (30.6) 03 (60) 0 02 (40) 05 (13.2) 0 33 (86.8)
Ciprofloxacin 07 (9.7) 06 (8.3) 59 (81.9) 03 (60) 01 (20) 01 (20) x x x
Moxifloxacin 01 (0.14) 0 71 (98.6) 0 0 05 (100) 04 (10.5) 04 (10.5) 30 (78.9)
Ampicillin 01 (1.4) 0 71 (98.6) 0 0 05 (100) 02 (5.3) 0 36 (94.7)
Gentamicin-Syn 02 (2.8) 0 72 (100) 0 0 05 (100) 01 (2.6) 0 01 (2.6)
Nitrofurantoin 0 0 72 (100) 01 (20) 01 (20) 03 (60) 01 (2.6) 03 (7.9) 34 (89.5)
Vancomycin 0 0 72 (100) 0 0 05 (100) 20 (52.6) 0 18 (47.4)
Teicoplanin 0 0 72 (100) 0 0 05 (100) 03 (7.9) 0 35 (92.1)
Linezolid 0 0 72 (100) 0 0 05 (100) 01 (2.6) 04 (10.5) 34 (89.5)
Daptomycin 0 0 64 (88.9) 0 0 01 (20) 0 0 07 (18.4)
MDR   NA NA   NA NA   NA NA
vanA 06 (15.8)
vanB 03 (7.9)
  1. S Susceptible, I Intermediate, R Resistant; −,Negative; x –MICs for these species (see “others”) are not reported by the Phoenix system
  2. MDR, multidrug resistant (isolate resistant to three or more antibiotic classes)
  3. “Others” denotes E. casseliflavus/gallinarum, E. raffinosus, E. hirae, E. durans, and the 10 isolates that were not identified to species level
\